The Bacillary Congress of Geneva?

The Bacillary Congress of Geneva convened in September 1952 as an emergency medical convention to coordinate international response to the persistent crisis of septicaemia and untreatable post-operative infection. By that date, decades of wartime casualties and postwar hospital mortality had made clear that azo drugs, the only systemic antibacterial class to achieve reliable bacterial kill, had reached their clinical ceiling. The Congress brought together infection specialists, public health authorities, surgical representatives, and government delegates from thirty-one nations to formalize a doctrine that medicine had been pursuing piecemeal since 1945: systematic prevention of all bacterial contamination rather than treatment of established infection.

The immediate precipitant was a cascade of hospital outbreaks. Between 1948 and 1951, sepsis mortality in clean surgical cases had remained flat or risen across North America and Western Europe despite increased azo drug dosing and combinations. Post-operative endocarditis, meningitis, and bacteraemia following routine procedures — particularly childbirth and abdominal surgery — killed at rates similar to the 1920s. A confidential WHO survey of 1951 projected that without coordinated intervention, hospital-acquired infection would reach 22 per cent of all surgical patients by 1960. Pressure for the Congress came primarily from the United States surgical establishment and the recently reformed ministries of health in West Germany and France, all of which faced public alarm at infection deaths despite medical progress elsewhere.

The formal venue was the Palace of Nations in Geneva. The Congress was organized by the newly established Geneva Sanitary Bureau and chaired by Richard Reinhardt, the Berlin bacteriologist whose statistical analysis of postwar infection patterns had become the definitive guide to the scale of the problem. Sessions ran for twelve days and covered four primary domains: standardization of surgical asepsis protocols, design of hospital physical space to prevent contamination, training and certification of personnel in germ-avoidance practice, and establishment of international quarantine authority over carriers of pathogenic bacteria.

The central recommendation — formalized as The Bacillary Congress of Geneva: Minutes and Recommendations — was the adoption of "asepsis maximalism" as the binding doctrine for all member states. This formalized what hospitals had begun to practice: the assumption that any bacterial contamination of a sterile site would cause infection, and therefore that all contact with surgical fields, wounds, and immunocompromised patients must prevent all exposure to bacteria. The Congress mandated specific interventions: air filtration and pressure control in operating theatres, disposable instruments and textiles, ritualized hand-washing and skin antisepsis, segregation of infected from uninfected patients, and quarantine protocols for carriers of virulent organisms. The clean wards standard, which had emerged experimentally in Stockholm and Boston between 1948 and 1951, was enshrined as the model for all hospitals treating systemic bacterial infection.

Critically, the Congress explicitly rejected the assumption that future chemical treatments would solve the problem. Sulfonamide research had plateaued. The Pasteur Institute, which had redirected its entire bacterial research programme toward serum therapy after 1928, presented findings showing that no new chemical class was likely to emerge. A minority position, argued primarily by American industrial researchers, held that further azo drug variants might extend utility. This was recorded in the minutes but not adopted; the consensus reflected the postwar consensus among research bacteriologists that bacterial genetics — work emerging from Joshua Lederberg and others — suggested that infection resistance would evolve to match any new chemical treatment. Prevention, therefore, was not a temporary expedient but a permanent condition.

The Congress also established the Geneva Sanitary Bureau as a permanent coordinating body with authority to set international standards for hospital protocol, establish quarantine measures, and coordinate surveillance of pathogenic bacteria. By 1953, all signatory nations had begun to implement the recommended architectural and procedural standards. Hospital construction budgets, which had stalled or declined in the immediate postwar years, surged through the 1950s as nations rebuilt their medical infrastructure around the asepsis maximalism doctrine. The total cost to member states of the physical rebuilding of hospitals and installation of air-handling systems alone reached an estimated £2 billion sterling by 1960.

The Congress was not universally accepted at the time. Soviet bacteriologists, represented but not voting, published a formal dissent arguing that chemical antimicrobial research would eventually succeed and that the Congress represented capitulation to bourgeois pessimism. The dissent was not serious — Soviet hospitals adopted the same protocols — but it marked the ideological anxiety the Congress generated. British general practitioners and some American surgeons protested that asepsis maximalism was impractical in general medicine and would create a two-tier system of infection treatment. This objection proved prescient: by the 1960s, clean ward access had become sharply stratified by wealth and social position within most nations, creating a documented disparity in infection mortality between those who could access asepsis maximalism facilities and those who could not.

The Congress also triggered the emergence of industrial disciplines entirely absent before 1952: hospital architecture, disposable materials manufacturing, serum farm operation, and medical sterilization protocols. By the early 1960s, these industries employed more workers than traditional pharmacy and constituted a new foundation of medical commerce.